Details of the Drug Formulations

General Information of Drug (ID: DMKMBES)

Drug Name
Plazomicin Drug Info
Synonyms ACHN-490; UNII-LYO9XZ250J; 1154757-24-0; LYO9XZ250J; Plazomicin [USAN:INN]; Plazomicin (USAN); ZINC68150640; DB12615; D10151; D-Streptamine,
Indication
Disease Entry ICD 11 Status REF
Bronchitis CA20 Approved [1]
Prostate disease GA91 Approved [1]
Urinary tract infection GC08 Approved [1]
Pancreatic cancer 2C10 Phase 3 [2]
Cross-matching ID
PubChem CID
42613186
CAS Number
1154757-24-0
TTD ID
D0E6BB
INTEDE ID
DR2136
ACDINA ID
D01346

Full List of Drug Formulations Containing This Drug

Plazomicin 500 mg/10 ml Injection
Company Formulation ID FDA Description
Cipla Usa F23258 Water; Sodium Hydroxide
------------------------------------------------------------------------------------

References

1 In vitro activity of plazomicin against -lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE).J Antimicrob Chemother. 2017 Oct 1;72(10):2792-2795.
2 ClinicalTrials.gov (NCT01970371) A Study of Plazomicin Compared With Colistin in Patients With Infection Due to Carbapenem-Resistant Enterobacteriaceae (CRE). U.S. National Institutes of Health.